Follow
Jean Claude Reubi
Jean Claude Reubi
Professor of Pathology, Cell Biology, University of Bern
Verified email at pathology.unibe.ch
Title
Cited by
Cited by
Year
Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients
EP Krenning, DJ Kwekkeboom, WH Bakker, WAP Breeman, PPM Kooij, ...
European journal of nuclear medicine 20, 716-731, 1993
19861993
Peptide receptors as molecular targets for cancer diagnosis and therapy
JC Reubi
Endocrine reviews 24 (4), 389-427, 2003
14532003
Affinity profiles for human somatostatin receptor subtypes SST1–SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use
JC Reubi, JC Schär, B Waser, S Wenger, A Heppeler, JS Schmitt, ...
European journal of nuclear medicine 27, 273-282, 2000
12762000
The role of somatostatin and its analogs in the diagnosis and treatment of tumors
SWJ Lamberts, EP Krenning, JC Reubi
Endocrine Reviews 12 (4), 450-482, 1991
10321991
Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin
EP Krenning, WAP Breeman, PPM Kooij, JS Lameris, WH Bakker, ...
The Lancet 333 (8632), 242-244, 1989
8821989
Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands
J Reubi, B Waser, JC Schaer, JA Laissue
European journal of nuclear medicine 28 (7), 836-846, 2001
8122001
Somatostatin-receptor imaging in the localization of endocrine tumors
SWJ Lamberts, WH Barker, JC Reubi, EP Krenning
New England Journal of Medicine 323 (18), 1246-1249, 1990
7011990
Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting
JC Reubi, B Waser
European journal of nuclear medicine and molecular imaging 30, 781-793, 2003
6832003
The VPAC2 receptor is essential for circadian function in the mouse suprachiasmatic nuclei
AJ Harmar, HM Marston, S Shen, C Spratt, KM West, WJ Sheward, ...
Cell 109 (4), 497-508, 2002
6402002
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours
U Plöckinger, G Rindi, R Arnold, B Eriksson, EP Krenning, WW De Herder, ...
Neuroendocrinology 80 (6), 394-424, 2004
6252004
Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation
R Markwalder, JC Reubi
Cancer research 59 (5), 1152-1159, 1999
6241999
Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide
EP Krenning, WH Bakker, PPM Kooij, WAP Breeman, HY Oei, M De Jong, ...
Journal of Nuclear Medicine 33 (5), 652-658, 1992
6061992
Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors
M Ginj, H Zhang, B Waser, R Cescato, D Wild, X Wang, J Erchegyi, ...
Proceedings of the National Academy of Sciences 103 (44), 16436-16441, 2006
5662006
GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting
M Körner, M Stöckli, B Waser, JC Reubi
Journal of Nuclear Medicine 48 (5), 736-743, 2007
4872007
Cholecystokinin (CCK)-A and CCK-B/gastrin receptors in human tumors
JC Reubi, JC Schaer, B Waser
Cancer research 57 (7), 1377-1386, 1997
4671997
Bombesin Receptor Subtypes in Human Cancers: Detection with the Universal Radioligand 125I-[d-TYR6, β-ALA11, PHE13, NLE14] Bombesin(6–14)
JC Reubi, S Wenger, J Schmuckli-Maurer, JC Schaer, M Gugger
Clinical Cancer Research 8 (4), 1139-1146, 2002
4552002
Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas
JC Reubi, LK Kvols, B Waser, DM Nagorney, PU Heitz, JW Charboneau, ...
Cancer research 50 (18), 5969-5977, 1990
4481990
Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?
P Antunes, M Ginj, H Zhang, B Waser, RP Baum, JC Reubi, H Maecke
European journal of nuclear medicine and molecular imaging 34, 982-993, 2007
4392007
DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals
D Wild, JS Schmitt, M Ginj, HR Mäcke, BF Bernard, E Krenning, ...
European journal of nuclear medicine and molecular imaging 30, 1338-1347, 2003
3802003
Expression and Localization of Somatostatin Receptor SSTR1, SSTR2, and SSTR3 Messenger RNAs in Primary Human Tumors using in Situ Hybridization
JC Reubi, JC Schaer, B Waser, G Mengod
Cancer Research 54 (13), 3455-3459, 1994
3801994
The system can't perform the operation now. Try again later.
Articles 1–20